MicroRNAs and diabetic complications

Area of Science:

• Endocrinology
• Molecular Biology
• Genetics

Background:

• Diabetes mellitus (Type 1 and Type 2) causes severe microvascular (retinopathy, nephropathy, neuropathy) and macrovascular (cardiovascular diseases, atherosclerosis, hypertension) complications.
• These complications are linked to hyperglycemia, hyperlipidemia, advanced glycation end products, growth factors, and inflammatory cytokines.
• Existing therapies are insufficient, necessitating a deeper understanding of molecular mechanisms for novel therapeutic targets.

Purpose of the Study:

• To review the critical role of microRNAs (miRNAs) in the pathology of diabetic complications.
• To explore the potential of miRNAs as diagnostic biomarkers and therapeutic targets for managing diabetic complications.

Main Methods:

• Literature review focusing on the molecular mechanisms of diabetic complications.
• Analysis of current research on microRNA function in disease pathology.
• Synthesis of evidence linking miRNAs to diabetic complication development.

Main Results:

• MicroRNAs (miRNAs) are short non-coding RNAs regulating gene expression post-transcriptionally.
• Emerging evidence highlights miRNAs' diverse cellular functions and involvement in various diseases, including diabetes.
• Specific miRNAs are implicated in the development and progression of diabetic microvascular and macrovascular complications.

Conclusions:

• MicroRNAs (miRNAs) represent a significant area of research in understanding diabetic complications.
• miRNAs hold promise as novel diagnostic tools and therapeutic targets for diabetes-related conditions.
• Further investigation into miRNA pathways is crucial for developing more effective treatments for diabetic complications.